A Prospective Randomized Trial of Povidone-iodine Suppository Before Transrectal Ultrasonography-guided Prostate Biopsy

Overview

Journal Medicine (Baltimore)

Specialty General Medicine

Date 2019 Mar 22

PMID 30896629

Citations 4

Authors

Hoyoung Ryu

Sang Hun Song

Sang Eun Lee

Kyoung-Ho Song

Sangchul Lee

Affiliations

Soon will be listed here.

Abstract

Objectives: To investigate a way to reduce infectious complication after transrectal ultrasonography-guided prostate biopsy (TRUS-Bx), we planned a randomized trial to determine whether the use of the povidone-iodine suppository is effective in preventing infectious complications.

Methods: This study prospectively assessed 250 patients who underwent TRUS-Bx during December 2014 and May 2016. Clinical questionnaire responses and safety were evaluated. Povidone-iodine suppository after glycerin enema was performed 1 to 2 hours before TRUS-Bx. Both groups received the prophylactic antibiotics (ceftriaxone 2.0 g) 30 to 60 minutes before TRUS-Bx. No antibiotics were prescribed after TRUS-Bx.

Results: The 120 were assigned in the treatment group using povidone-iodine suppository and 130 were assigned in the control group. There was no significant difference of clinicopathologic features including age, prostate-specific antigen and cancer detection rate in both groups (P > .05). No infectious and non-infectious complications were reported in both groups. Povidone-iodine suppository-related side effects were not reported. No significant differences in international prostate symptom score, sexual health inventory for men score, and European Organization for Research and Treatment of Cancer Quality of Life questionnaire scores were found between the 2 groups (P > .05). No changes in each questionnaire scores between before and after TRUS-Bx were observed.

Conclusions: Despite satisfying the predefined sample size, we could not prove the hypothesis that the use of povidone-iodine suppositories after TRUS-Bx would reduce infectious complications. A large-scale, multicenter, prospective study is needed to fully evaluate the clinical efficacy and safety of povidone-iodine suppository prior to TRUS-Bx.

Citing Articles

Prevention of infectious complications after transrectal ultrasound-guided prostate biopsy: comparison of povidone-iodine, chlorhexidine, and formalin disinfection.

Basaranoglu M, Nebioglu A, Bozlu M, Gokce A, Akbay E World J Urol. 2025; 43(1):107.

PMID: 39918597 PMC: 11805847. DOI: 10.1007/s00345-025-05498-4.

Role of Perilesional Sampling of Patients Undergoing Fusion Prostate Biopsies.

Lombardo R, Tema G, Nacchia A, Mancini E, Franco S, Zammitti F Life (Basel). 2023; 13(8).

PMID: 37629576 PMC: 10455324. DOI: 10.3390/life13081719.

Transrectal povidone-iodine efficiency in reducing infections occurring after transrectal ultrasound guided biopsy of the prostate.

Siyez E Medicine (Baltimore). 2021; 100(41):e27539.

PMID: 34731153 PMC: 8519225. DOI: 10.1097/MD.0000000000027539.

Minimizing transrectal prostate biopsy-related infections; A prospective randomized trial of povidone-iodine intrarectal cleaning versus formalin needle disinfection.

Bajpai R, Razdan S, Sanchez-Gonzalez M, Razdan S Indian J Urol. 2021; 37(3):254-260.

PMID: 34465955 PMC: 8388331. DOI: 10.4103/iju.IJU_34_21.

A novel method for pain control: infiltration free local anesthesia technique (INFLATE) for transrectal prostatic biopsy using transcutaneous electrical nerve stimulation (TENS).

Bolat M, Cinar O, Asci R, Buyukalpelli R Int Urol Nephrol. 2019; 51(12):2119-2126.

PMID: 31493104 DOI: 10.1007/s11255-019-02277-0.

References

Lee J, Lee S, Hong S, Byun S, Lee S . Clinical importance of the antibiotic regimen in transrectal ultrasound-guided biopsy: quinolone versus cephalosporin. BMC Urol. 2016; 16(1):51. PMC: 4997763. DOI: 10.1186/s12894-016-0169-z. View

Zani E, Clark O, Rodrigues Netto Jr N . Antibiotic prophylaxis for transrectal prostate biopsy. Cochrane Database Syst Rev. 2011; (5):CD006576. DOI: 10.1002/14651858.CD006576.pub2. View

Al-Hasan M, Lahr B, Eckel-Passow J, Baddour L . Antimicrobial resistance trends of Escherichia coli bloodstream isolates: a population-based study, 1998-2007. J Antimicrob Chemother. 2009; 64(1):169-74. PMC: 2692504. DOI: 10.1093/jac/dkp162. View

Park D, Oh J, Lee J, Jang W, Hong Y, Hong S . Simple use of the suppository type povidone-iodine can prevent infectious complications in transrectal ultrasound-guided prostate biopsy. Adv Urol. 2009; :750598. PMC: 2673474. DOI: 10.1155/2009/750598. View

Kehinde E, Al-Maghrebi M, Sheikh M, Anim J . Combined ciprofloxacin and amikacin prophylaxis in the prevention of septicemia after transrectal ultrasound guided biopsy of the prostate. J Urol. 2012; 189(3):911-5. DOI: 10.1016/j.juro.2012.08.237. View

Walker J, Singla N, Roehrborn C . Reducing Infectious Complications Following Transrectal Ultrasound-guided Prostate Biopsy: A Systematic Review. Rev Urol. 2016; 18(2):73-89. PMC: 5010628. DOI: 10.3909/riu0713. View

Scott S, Harris P, Williamson D, Liss M, Doi S, Roberts M . The effectiveness of targeted relative to empiric prophylaxis on infectious complications after transrectal ultrasound-guided prostate biopsy: a meta-analysis. World J Urol. 2018; 36(7):1007-1017. DOI: 10.1007/s00345-018-2217-7. View

Ruddick F, Sanders P, Bicknell S, Crofts P . Sepsis rates after ultrasound-guided prostate biopsy using a bowel preparation protocol in a community hospital. J Ultrasound Med. 2011; 30(2):213-6. DOI: 10.7863/jum.2011.30.2.213. View

Ferro M, Mirone V, Musi G, de Cobelli O, Creta M . Patient Selection for Active Surveillance in the Multi-parametric Magnetic Resonance Imaging Era: A Step Forward in a Rapidly Evolving Field. Ann Surg Oncol. 2018; 25(12):3423-3424. DOI: 10.1245/s10434-018-6746-5. View

10.

Czeizel A, Kazy Z, Vargha P . Vaginal treatment with povidone--iodine suppositories during pregnancy. Int J Gynaecol Obstet. 2003; 84(1):83-5. DOI: 10.1016/s0020-7292(03)00270-4. View

11.

Chung H, Hwang E, Yu H, Jung S, Lee S, Lim D . Prevalence of fluoroquinolone-resistant rectal flora in patients undergoing transrectal ultrasound-guided prostate needle biopsy: A prospective multicenter study. Int J Urol. 2017; 25(3):278-283. DOI: 10.1111/iju.13511. View

12.

Huang Y, Ho D, Wu C, Shee J, Lin W, Chen C . Modified bowel preparation to reduce infection after prostate biopsy. Chang Gung Med J. 2006; 29(4):395-400. View

13.

Yildirim M, Badem H, Cavis M, Karatas O, Cimentepe E, Unal D . The comparison of the influence between two different bowel preparation methods on sepsis after prostate biopsies. Cent European J Urol. 2015; 68(1):91-4. PMC: 4408382. DOI: 10.5173/ceju.2015.01.424. View

14.

Loeb S, Carter H, Berndt S, Ricker W, Schaeffer E . Complications after prostate biopsy: data from SEER-Medicare. J Urol. 2011; 186(5):1830-4. PMC: 9840843. DOI: 10.1016/j.juro.2011.06.057. View

15.

Asghania M, Mirblouk F, Shakiba M, Faraji R . Preoperative vaginal preparation with povidone-iodine on post-caesarean infectious morbidity. J Obstet Gynaecol. 2011; 31(5):400-3. DOI: 10.3109/01443615.2011.568644. View

16.

Cormio L, Cindolo L, Troiano F, Marchioni M, Di Fino G, Mancini V . Development and Internal Validation of Novel Nomograms Based on Benign Prostatic Obstruction-Related Parameters to Predict the Risk of Prostate Cancer at First Prostate Biopsy. Front Oncol. 2018; 8:438. PMC: 6198078. DOI: 10.3389/fonc.2018.00438. View

17.

Kamei J, Yagihara Y, Kume H, Horiuchi T, Sato T, Nakagawa T . Prevalence and characteristics of fecal antimicrobial-resistant Escherichia coli in a cohort of Japanese men undergoing prostate biopsy. Int J Urol. 2017; 24(4):295-300. DOI: 10.1111/iju.13308. View

18.

Cormio L, Lucarelli G, Selvaggio O, Di Fino G, Mancini V, Massenio P . Absence of Bladder Outlet Obstruction Is an Independent Risk Factor for Prostate Cancer in Men Undergoing Prostate Biopsy. Medicine (Baltimore). 2016; 95(7):e2551. PMC: 4998598. DOI: 10.1097/MD.0000000000002551. View

19.

Loeb S, van den Heuvel S, Zhu X, Bangma C, Schroder F, Roobol M . Infectious complications and hospital admissions after prostate biopsy in a European randomized trial. Eur Urol. 2012; 61(6):1110-4. DOI: 10.1016/j.eururo.2011.12.058. View

20.

Cussans A, Somani B, Basarab A, Dudderidge T . The role of targeted prophylactic antimicrobial therapy before transrectal ultrasonography-guided prostate biopsy in reducing infection rates: a systematic review. BJU Int. 2015; 117(5):725-31. DOI: 10.1111/bju.13402. View